Consumers of the Heartburn Drug Zantac® Who’ve Been Diagnosed With Pancreatic Cancer Are Urged To Request a Free, Private Case Evaluation For Justice and Compensation
Consumers of the Heartburn Drug Zantac® Who’ve Been Diagnosed With Pancreatic Cancer Are Urged To Request a Free, Private Case Evaluation For Justice and Compensation
Consumers encouraged to seek out legal case evaluations for conditions such as…
- Abdominal pain that radiates to the back;
- Loss of appetite or unintended weight loss;
- Yellowing of the skin and the whites of the eyes (jaundice);
- Light-colored stools;
- Dark-colored urine;
- Itchy skin;
- New diagnosis of diabetes or existing diabetes that's becoming more difficult to control; and,
- Blood clots.
FREE CLAIM REVIEW
By clicking the "Free Case Review" button, I consent to receive recurring auto dialed and/or pre-recorded telemarketing calls and/or text messages from Shield Legal LP or our partners in order to discuss my legal options and at the telephone number I provided. I also consent to the Shield Legal LP Privacy Policy and Terms of Use. I understand that I may receive a call even if my telephone number is listed on a Do Not Call list and that my consent is not a requirement of purchase. I understand that my telephone company may impose charges on me for these contacts and that I can revoke this consent at any time. For SMS campaigns: Text STOP to cancel and HELP for help. Msg & data rates may apply. Recurring msgs up to 27 msgs per month.
100% confidential Case Evaluations
Answer a few basic questions to get started
Receive a confidential case evaluation
Have an individual claim filed for compensation
Billions in profits made on unsafe Medication
How does Zantac® (aka ranitidine®) cause pancreatic cancer?
Glaxo Holdings Ltd® (aka GSK® or GlaxoSmithKline®) created and sold Zantac® beginning in 1983 to reduce excess acid produced in stomach cells.
Zantac® was initially approved only for short-term use by the Federal Drug Administration (FDA) due to its potential to cause cancer in long-term use–however, it was then marketed for long-term use without appropriate warnings of the cancer-causing potential.
Since Zantac® (aka ranitidine®) has potentially been linked to several types of lifelong cancers–namely pancreatic cancer–because it contains dangerously high levels of a potentially dangerous chemical called N-nitrosodimethylamine (NDMA).
Shield Legal Network believes that consumers diagnosed with pancreatic cancer must get the justice and compensation they deserve, starting by addressing the makers of Zantac® (aka ranitidine®) in a court of law.
Zantac® and Pancreatic Cancer in the News
2020
In January 2020, an Ohio man filed a Zantac® lawsuit in the U.S. District Court for the Northern District of Ohio–he was diagnosed with pancreatic cancer after taking Zantac® (aka ranitidine®) for 24 years and claimed the manufacturers should be held liable.
2020
The surviving family member of a Pennsylvania man who died from pancreatic cancer last year has filed a wrongful death lawsuit against the makers of Zantac®, alleging that years of exposure to carcinogenic chemicals in the recalled heartburn drug caused her loved one’s death.
2020
Given common questions of fact and law, several Zantac lawsuits have been centralized for coordinated pretrial proceedings before the U.S. District Judge Robin L. Rosenberg in the Southern District of Florida.
